DnB Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.7M | Sell |
48,254
-17,547
| -27% | -$6.51M | 0.05% | 230 |
|
|
2026
Q1 | $19.3M | Sell |
65,801
-8,505
| -11% | -$2.8M | 0.07% | 187 |
|
|
2025
Q4 | $26M | Buy |
74,306
+32,048
| +76% | +$10.8M | 0.09% | 146 |
|
|
2025
Q3 | $13.7M | Buy |
42,258
+1,378
| +3% | +$429K | 0.05% | 236 |
|
|
2025
Q2 | $15.9M | Sell |
40,880
-1,615
| -4% | -$650K | 0.07% | 193 |
|
|
2025
Q1 | $18.5M | Sell |
42,495
-16,751
| -28% | -$6.72M | 0.09% | 168 |
|
|
2024
Q4 | $21.9M | Buy |
59,246
+3,263
| +6% | +$1.37M | 0.09% | 162 |
|
|
2024
Q3 | $29.1M | Sell |
55,983
-14,666
| -21% | -$7.83M | 0.13% | 126 |
|
|
2024
Q2 | $38.3M | Buy |
70,649
+13,643
| +24% | +$7.21M | 0.18% | 91 |
|
|
2024
Q1 | $29.6M | Sell |
57,006
-26,699
| -32% | -$13.3M | 0.15% | 110 |
|
|
2023
Q4 | $39.5M | Buy |
83,705
+6,710
| +9% | +$3.1M | 0.2% | 90 |
|
|
2023
Q3 | $33.5M | Buy |
76,995
+8,031
| +12% | +$3.64M | 0.2% | 94 |
|
|
2023
Q2 | $30.6M | Sell |
68,964
-73
| -0.1% | -$33.7K | 0.18% | 111 |
|
|
2023
Q1 | $31.7M | Buy |
69,037
+893
| +1% | +$425K | 0.2% | 102 |
|
|
2022
Q4 | $35M | Sell |
68,144
-695
| -1% | -$353K | 0.25% | 91 |
|
|
2022
Q3 | $31.3M | Buy |
68,839
+526
| +0.8% | +$252K | 0.24% | 95 |
|
|
2022
Q2 | $33M | Sell |
68,313
-2,309
| -3% | -$1.14M | 0.23% | 103 |
|
|
2022
Q1 | $34.7M | Buy |
70,622
+795
| +1% | +$363K | 0.21% | 101 |
|
|
2021
Q4 | $32.4M | Buy |
69,827
+6,559
| +10% | +$2.76M | 0.19% | 109 |
|
|
2021
Q3 | $23.6M | Buy |
63,268
+2,654
| +4% | +$1.01M | 0.15% | 129 |
|
|
2021
Q2 | $23.1M | Buy |
60,614
+23,939
| +65% | +$9.15M | 0.15% | 126 |
|
|
2021
Q1 | $13.2M | Buy |
36,675
+396
| +1% | +$127K | 0.1% | 163 |
|
|
2020
Q4 | $11.6M | Sell |
36,279
-151
| -0.4% | -$46.3K | 0.1% | 162 |
|
|
2020
Q3 | $9.78M | Buy |
36,430
+3,110
| +9% | +$837K | 0.1% | 145 |
|
|
2020
Q2 | $8.76M | Sell |
33,320
-1,156
| -3% | -$308K | 0.1% | 152 |
|
|
2020
Q1 | $7.83M | Sell |
34,476
-25,087
| -42% | -$6.84M | 0.12% | 137 |
|
|
2019
Q4 | $18M | Sell |
59,563
-15,272
| -20% | -$4.2M | 0.18% | 101 |
|
|
2019
Q3 | $18M | Sell |
74,835
-42,571
| -36% | -$11.7M | 0.2% | 90 |
|
|
2019
Q2 | $33.1M | Buy |
117,406
+17,850
| +18% | +$4.88M | 0.38% | 53 |
|
|
2019
Q1 | $28.6M | Sell |
99,556
-16,073
| -14% | -$4.65M | 0.33% | 59 |
|
|
2018
Q4 | $30.4M | Buy |
115,629
+26,617
| +30% | +$7.32M | 0.39% | 61 |
|
|
2018
Q3 | $24.4M | Sell |
89,012
-13,438
| -13% | -$3.49M | 0.27% | 69 |
|
|
2018
Q2 | $24.4M | Buy |
102,450
+2,000
| +2% | +$463K | 0.29% | 70 |
|
|
2018
Q1 | $22.1M | Buy |
100,450
+17,000
| +20% | +$3.99M | 0.27% | 76 |
|
|
2017
Q4 | $18.8M | Sell |
83,450
-56,900
| -41% | -$12.1M | 0.23% | 85 |
|
|
2017
Q3 | $26.6M | Buy |
140,350
+23,300
| +20% | +$4.43M | 0.35% | 64 |
|
|
2017
Q2 | $22M | Buy |
117,050
+24,700
| +27% | +$4.44M | 0.32% | 67 |
|
|
2017
Q1 | $15.3M | Sell |
92,350
-19,600
| -18% | -$3.12M | 0.24% | 84 |
|
|
2016
Q4 | $16.1M | Buy |
111,950
+3,300
| +3% | +$442K | 0.3% | 76 |
|
|
2016
Q3 | $13.6M | Buy |
108,650
+35,900
| +49% | +$4.64M | 0.27% | 84 |
|
|
2016
Q2 | $9.55M | Buy |
72,750
+6,800
| +10% | +$930K | 0.2% | 99 |
|
|
2016
Q1 | $9.17M | Sell |
65,950
-12,300
| -16% | -$1.64M | 0.19% | 105 |
|
|
2015
Q4 | $10.9M | Sell |
78,250
-297,086
| -79% | -$40.9M | 0.23% | 89 |
|
|
2015
Q3 | $52.5M | Buy |
375,336
+310,286
| +477% | +$46.6M | 1.31% | 18 |
|
|
2015
Q2 | $10.7M | Sell |
65,050
-14,700
| -18% | -$2.35M | 0.24% | 83 |
|
|
2015
Q1 | $12.3M | Buy |
79,750
+30,100
| +61% | +$4.29M | 0.27% | 79 |
|
|
2014
Q4 | $6.24M | Buy |
49,650
+20,500
| +70% | +$2.53M | 0.14% | 132 |
|
|
2014
Q3 | $3.49M | Sell |
29,150
-4,800
| -14% | -$551K | 0.08% | 164 |
|
|
2014
Q2 | $3.65M | Buy |
+33,950
| New | +$3.5M | 0.08% | 169 |
|
|
2013
Q4 | $3.42M | Buy |
37,050
+11,200
| +43% | +$995K | 0.08% | 140 |
|
|
2013
Q3 | $2.16M | Sell |
25,850
-500
| -2% | -$42.9K | 0.06% | 132 |
|
|
2013
Q2 | $2.16M | Buy |
+26,350
| New | +$1.97M | 0.06% | 138 |
|
Other funds holding ELV
N
DnB Asset Management's ELV Position: Q2 2026 in Review
DnB Asset Management reduced its Elevance Health (ELV) stake by 27% in Q2 2026, selling an estimated $6.51M and leaving 48,254 shares worth $18.7M. The position accounts for 0.05% of the portfolio, ranked #230.
DnB Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.5M in Q3 2015. 1,076 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- DnB Asset Management held 48,254 shares of Elevance Health worth $18.7M as of Q2 2026.
- DnB Asset Management sold 17,547 Elevance Health shares in Q2 2026, an estimated $6.51M.
- Elevance Health made up 0.05% of DnB Asset Management's portfolio in Q2 2026, its #230 holding.
- DnB Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- DnB Asset Management's Elevance Health position peaked at $52.5M in Q3 2015.
- 1,076 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.